# Vinay Sikand, M.D. – FDA Inspection, Sep 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/vinay-sikand-md/1e9af967-6de5-45ba-b5fd-1412c91dea47
Source feed: FDA_Inspections

> FDA inspection 1217800 of Vinay Sikand, M.D., September 14, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217800
- Company Name: Vinay Sikand, M.D.
- Inspection Date: 2023-09-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1290456 - 2025-10-28

## Related Officers

- [Investigator](https://www.keypedia.com/people/mayar-m-mussa/4f39b1c8-93a6-4bc9-a800-5f802db48be6)
- [Company Rep](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)

Company: https://www.keypedia.com/companies/vinay-sikand-md/cc615f5c-4541-4813-a81d-92f4f29b316a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
